Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Peri-tumoral Metallic Implants Reduce the Efficacy of Irreversible Electroporation for the Ablation of Colorectal Liver Metastases.

Cornelis FH, Cindrič H, Kos B, Fujimori M, Petre EN, Miklavčič D, Solomon SB, Srimathveeravalli G.

Cardiovasc Intervent Radiol. 2019 Aug 5. doi: 10.1007/s00270-019-02300-y. [Epub ahead of print]

PMID:
31385006
2.

Utility of Core Biopsy Specimen to Identify Histologic Subtype and Predict Outcome for Lung Adenocarcinoma.

Kim TH, Buonocore D, Petre EN, Durack JC, Maybody M, Johnston RP, Travis WD, Adusumilli PS, Solomon SB, Ziv E.

Ann Thorac Surg. 2019 Aug;108(2):392-398. doi: 10.1016/j.athoracsur.2019.03.043. Epub 2019 Apr 12.

PMID:
30986416
3.

Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression.

Kaye EA, Cornelis FH, Petre EN, Tyagi N, Shady W, Shi W, Zhang Z, Solomon SB, Sofocleous CT, Durack JC.

Eur Radiol. 2019 May;29(5):2698-2705. doi: 10.1007/s00330-018-5809-0. Epub 2018 Nov 6.

PMID:
30402706
4.

DAXX Mutation Status of Embolization-Treated Neuroendocrine Tumors Predicts Shorter Time to Hepatic Progression.

Ziv E, Rice SL, Filtes J, Yarmohammadi H, Boas FE, Erinjeri JP, Petre EN, Brody LA, Brown KT, Covey AM, Getrajdman GI, Maybody M, Raj N, Sofocleous CT, Solomon SB, Reidy-Lagunes D.

J Vasc Interv Radiol. 2018 Nov;29(11):1519-1526. doi: 10.1016/j.jvir.2018.05.023. Epub 2018 Oct 19.

PMID:
30342802
5.

Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases.

Kurilova I, Beets-Tan RGH, Flynn J, Gönen M, Ulaner G, Petre EN, Edward Boas F, Ziv E, Yarmohammadi H, Klompenhouwer EG, Cercek A, Kemeny NA, Sofocleous CT.

Clin Colorectal Cancer. 2019 Mar;18(1):8-18. doi: 10.1016/j.clcc.2018.08.004. Epub 2018 Sep 13.

PMID:
30297264
6.

Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases.

Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, Erinjeri J, Petre EN, Gonen M, Bains M, Kemeny NE, Solomon SB, Sofocleous CT.

Cardiovasc Intervent Radiol. 2018 Oct;41(10):1530-1544. doi: 10.1007/s00270-018-2000-6. Epub 2018 May 29.

PMID:
29845348
7.

90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full-Strength Contrast Material.

Kurilova I, Beets-Tan RGH, Ulaner GA, Boas FE, Petre EN, Yarmohammadi H, Ziv E, Deipolyi AR, Brody LA, Gonen M, Sofocleous CT.

Cardiovasc Intervent Radiol. 2018 Sep;41(9):1419-1427. doi: 10.1007/s00270-018-1985-1. Epub 2018 May 15.

PMID:
29766239
8.

Immediate Postablation 18F-FDG Injection and Corresponding SUV Are Surrogate Biomarkers of Local Tumor Progression After Thermal Ablation of Colorectal Carcinoma Liver Metastases.

Cornelis FH, Petre EN, Vakiani E, Klimstra D, Durack JC, Gonen M, Osborne J, Solomon SB, Sofocleous CT.

J Nucl Med. 2018 Sep;59(9):1360-1365. doi: 10.2967/jnumed.117.194506. Epub 2018 Feb 9.

9.

Arms Down Cone Beam CT Hepatic Angiography Performance Assessment: Vascular Imaging Quality and Imaging Artifacts.

Gonzalez-Aguirre AJ, Petre EN, Hsu M, Moskowitz CS, Solomon SB, Durack JC.

Cardiovasc Intervent Radiol. 2018 Jun;41(6):898-904. doi: 10.1007/s00270-017-1875-y. Epub 2018 Jan 11.

PMID:
29327076
10.

Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.

Shady W, Petre EN, Do KG, Gonen M, Yarmohammadi H, Brown KT, Kemeny NE, D'Angelica M, Kingham PT, Solomon SB, Sofocleous CT.

J Vasc Interv Radiol. 2018 Feb;29(2):268-275.e1. doi: 10.1016/j.jvir.2017.08.021. Epub 2017 Dec 6.

11.

Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.

Shady W, Petre EN, Vakiani E, Ziv E, Gonen M, Brown KT, Kemeny NE, Solomon SB, Solit DB, Sofocleous CT.

Oncotarget. 2017 Aug 2;8(39):66117-66127. doi: 10.18632/oncotarget.19806. eCollection 2017 Sep 12.

12.

Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences?

Vroomen LGPH, Petre EN, Cornelis FH, Solomon SB, Srimathveeravalli G.

Diagn Interv Imaging. 2017 Sep;98(9):609-617. doi: 10.1016/j.diii.2017.07.007. Epub 2017 Aug 30. Review.

13.

Efficiency of combined blocking of aerobic and glycolytic metabolism pathways in treatment of N1-S1 hepatocellular carcinoma in a rat model.

Yarmohammadi H, Wilkins LR, Erinjeri JP, Novak RD, Exner AA, Wu H, Petre EN, Boas E, Ziv E, Haaga JR.

J Cancer Res Ther. 2017 Jul-Sep;13(3):533-537. doi: 10.4103/0973-1482.172127.

14.

Erratum to: Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.

Gao S, Stein S, Petre EN, Shady W, Durack JC, Ridge C, Adusumilli PS, Rekhtman N, Solomon SB, Ziv E.

Cardiovasc Intervent Radiol. 2017 Oct;40(10):1658. doi: 10.1007/s00270-017-1767-1. No abstract available.

PMID:
28799111
15.

Hepatic Arterial Embolization Using Cone Beam CT with Tumor Feeding Vessel Detection Software: Impact on Hepatocellular Carcinoma Response.

Cornelis FH, Borgheresi A, Petre EN, Santos E, Solomon SB, Brown K.

Cardiovasc Intervent Radiol. 2018 Jan;41(1):104-111. doi: 10.1007/s00270-017-1758-2. Epub 2017 Aug 2.

PMID:
28770316
16.

Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.

Gao S, Stein S, Petre EN, Shady W, Durack JC, Ridge C, Adusumilli P, Rekhtman N, Solomon SB, Ziv E.

Cardiovasc Intervent Radiol. 2018 Feb;41(2):253-259. doi: 10.1007/s00270-017-1760-8. Epub 2017 Aug 2. Erratum in: Cardiovasc Intervent Radiol. 2017 Aug 10;:.

17.

Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.

Petre EN, Sofocleous C.

Visc Med. 2017 Mar;33(1):62-68. doi: 10.1159/000454697. Epub 2017 Feb 3. Review.

18.

PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.

Ziv E, Bergen M, Yarmohammadi H, Boas FE, Petre EN, Sofocleous CT, Yaeger R, Solit DB, Solomon SB, Erinjeri JP.

Oncotarget. 2017 Apr 4;8(14):23529-23538. doi: 10.18632/oncotarget.15278.

19.

Gene Signature Associated with Upregulation of the Wnt/β-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization.

Ziv E, Yarmohammadi H, Boas FE, Petre EN, Brown KT, Solomon SB, Solit D, Reidy D, Erinjeri JP.

J Vasc Interv Radiol. 2017 Mar;28(3):349-355.e1. doi: 10.1016/j.jvir.2016.11.004. Epub 2017 Jan 24.

20.

The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.

Ierardi AM, Angileri SA, Patella F, Panella S, Lucchina N, Petre EN, Pinto A, Franceschelli G, Carrafiello G, Cornalba G, Sofocleous CT.

Med Oncol. 2017 Jan;34(1):11. doi: 10.1007/s12032-016-0866-1. Epub 2016 Dec 22. Review.

PMID:
28008570
21.

Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation.

Ziv E, Erinjeri JP, Yarmohammadi H, Boas FE, Petre EN, Gao S, Shady W, Sofocleous CT, Jones DR, Rudin CM, Solomon SB.

Radiology. 2017 Jan;282(1):251-258. doi: 10.1148/radiol.2016160003. Epub 2016 Jul 19.

22.

Acute and delayed bleeding requiring embolization after image-guided liver biopsy in patients with cancer.

Sag AA, Brody LA, Maybody M, Erinjeri JP, Wang X, Wimmer T, Silk M, Petre EN, Solomon SB.

Clin Imaging. 2016 May-Jun;40(3):535-40. doi: 10.1016/j.clinimag.2015.11.004. Epub 2015 Nov 14.

PMID:
27133700
23.

Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.

Sotirchos VS, Petrovic LM, Gönen M, Klimstra DS, Do RK, Petre EN, Garcia AR, Barlas A, Erinjeri JP, Brown KT, Covey AM, Alago W, Brody LA, DeMatteo RP, Kemeny NE, Solomon SB, Manova-Todorova KO, Sofocleous CT.

Radiology. 2016 Sep;280(3):949-59. doi: 10.1148/radiol.2016151005. Epub 2016 Mar 24.

24.

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.

Sofocleous CT, Violari EG, Sotirchos VS, Shady W, Gonen M, Pandit-Taskar N, Petre EN, Brody LA, Alago W, Do RK, D'Angelica MI, Osborne JR, Segal NH, Carrasquillo JA, Kemeny NE.

Clin Colorectal Cancer. 2015 Dec;14(4):296-305. doi: 10.1016/j.clcc.2015.06.003. Epub 2015 Jun 27.

25.

Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.

Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, Alago W, Durack JC, Maybody M, Brody LA, Siegelbaum RH, D'Angelica MI, Jarnagin WR, Solomon SB, Kemeny NE, Sofocleous CT.

Radiology. 2016 Feb;278(2):601-11. doi: 10.1148/radiol.2015142489. Epub 2015 Aug 12.

26.

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla.

Sotirchos VS, Petre EN, Brown KT, Brody LA, D'Angelica MI, DeMatteo RP, Kemeny NE, Sofocleous CT.

Case Reports Hepatol. 2014;2014:921406. doi: 10.1155/2014/921406. Epub 2014 Dec 17.

27.

Safety and efficacy of percutaneous cecostomy/colostomy for treatment of large bowel obstruction in adults with cancer.

Tewari SO, Getrajdman GI, Petre EN, Sofocleous CT, Siegelbaum RH, Erinjeri JP, Weiser MR, Thornton RH.

J Vasc Interv Radiol. 2015 Feb;26(2):182-8. doi: 10.1016/j.jvir.2014.09.022. Epub 2014 Dec 17.

PMID:
25529188
28.

Ablative and catheter-directed therapies for colorectal liver and lung metastases.

Petre EN, Sofocleous CT, Solomon SB.

Hematol Oncol Clin North Am. 2015 Feb;29(1):117-33. doi: 10.1016/j.hoc.2014.09.007. Review.

PMID:
25475575
29.

The role of percutaneous image-guided ablation for lung tumors.

Petre EN, Solomon SB, Sofocleous CT.

Radiol Med. 2014 Jul;119(7):541-8. doi: 10.1007/s11547-014-0427-7. Epub 2014 Jul 1. Review.

PMID:
24981483
30.

Microwave ablation (MWA) for the treatment of a solitary, chemorefractory testicular cancer liver metastasis.

Violari EG, Petre EN, Feldman DR, Erinjeri JP, Brown KT, Solomon SB, D'Angelica MI, Sofocleous CT.

Cardiovasc Intervent Radiol. 2015 Apr;38(2):488-93. doi: 10.1007/s00270-014-0924-z. Epub 2014 Jun 18.

PMID:
24938904
31.

Radiofrequency ablation of T1 lung carcinoma: comparison of outcomes for first primary, metachronous, and synchronous lung tumors.

Ridge CA, Silk M, Petre EN, Erinjeri JP, Alago W, Downey RJ, Sofocleous CT, Thornton RH, Solomon SB.

J Vasc Interv Radiol. 2014 Jul;25(7):989-96. doi: 10.1016/j.jvir.2014.02.021. Epub 2014 Apr 2.

PMID:
24703321
32.

Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.

Sofocleous CT, Garcia AR, Pandit-Taskar N, Do KG, Brody LA, Petre EN, Capanu M, Longing AP, Chou JF, Carrasquillo JA, Kemeny NE.

Clin Colorectal Cancer. 2014 Mar;13(1):27-36. doi: 10.1016/j.clcc.2013.11.010. Epub 2013 Nov 13.

PMID:
24370352
33.

Factors affecting periprocedural morbidity and mortality and long-term patient survival after arterial embolization of hepatic neuroendocrine metastases.

Sofocleous CT, Petre EN, Gonen M, Reidy-Lagunes D, Ip IK, Alago W, Covey AM, Erinjeri JP, Brody LA, Maybody M, Thornton RH, Solomon SB, Getrajdman GI, Brown KT.

J Vasc Interv Radiol. 2014 Jan;25(1):22-30; quiz 31. doi: 10.1016/j.jvir.2013.09.013.

PMID:
24365504
34.

"How we do it" - a practical approach to hepatic metastases ablation techniques.

Sofocleous CT, Sideras P, Petre EN.

Tech Vasc Interv Radiol. 2013 Dec;16(4):219-29. doi: 10.1053/j.tvir.2013.08.005. Review.

PMID:
24238377
35.

Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation.

Sofocleous CT, Garg SK, Cohen P, Petre EN, Gonen M, Erinjeri JP, Downey RJ, Travis WD, Solomon SB.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S676-83. doi: 10.1245/s10434-013-3140-1. Epub 2013 Jul 30.

PMID:
23897007
36.

Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.

Hyder O, Marsh JW, Salem R, Petre EN, Kalva S, Liapi E, Cosgrove D, Neal D, Kamel I, Zhu AX, Sofocleous CT, Geschwind JF, Pawlik TM.

Ann Surg Oncol. 2013 Nov;20(12):3779-86. doi: 10.1245/s10434-013-3127-y. Epub 2013 Jul 12.

PMID:
23846786
37.

Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation.

Tewari SO, Petre EN, Osborne J, Sofocleous CT.

Cardiovasc Intervent Radiol. 2013 Dec;36(6):1704-1706. doi: 10.1007/s00270-013-0692-1. Epub 2013 Jul 10.

PMID:
23839009
38.

Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC<7 cm.

Elnekave E, Erinjeri JP, Brown KT, Thornton RH, Petre EN, Maybody M, Maluccio MA, Hsu M, Sofocleous CT, Getrajdman GI, Brody LA, Solomon SB, Alago W, Fong Y, Jarnagin WR, Covey AM.

Ann Surg Oncol. 2013 Sep;20(9):2881-6. doi: 10.1245/s10434-013-2961-2. Epub 2013 Apr 7.

39.

Treatment of pulmonary colorectal metastases by radiofrequency ablation.

Petre EN, Jia X, Thornton RH, Sofocleous CT, Alago W, Kemeny NE, Solomon SB.

Clin Colorectal Cancer. 2013 Mar;12(1):37-44. doi: 10.1016/j.clcc.2012.07.003. Epub 2012 Sep 29.

PMID:
23026111
40.

Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies.

Sofocleous CT, Garg S, Petrovic LM, Gonen M, Petre EN, Klimstra DS, Solomon SB, Brown KT, Brody LA, Covey AM, Dematteo RP, Schwartz L, Kemeny NE.

Ann Surg Oncol. 2012 Dec;19(13):4262-9. doi: 10.1245/s10434-012-2461-9. Epub 2012 Jul 3.

41.

Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Wang X, Sofocleous CT, Erinjeri JP, Petre EN, Gonen M, Do KG, Brown KT, Covey AM, Brody LA, Alago W, Thornton RH, Kemeny NE, Solomon SB.

Cardiovasc Intervent Radiol. 2013 Feb;36(1):166-75. doi: 10.1007/s00270-012-0377-1. Epub 2012 Apr 26.

42.

Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy.

Waitz R, Solomon SB, Petre EN, Trumble AE, Fassò M, Norton L, Allison JP.

Cancer Res. 2012 Jan 15;72(2):430-9. doi: 10.1158/0008-5472.CAN-11-1782. Epub 2011 Nov 22.

43.

Ablation for the management of pulmonary malignancies.

Sofocleous CT, Sideras P, Petre EN, Solomon SB.

AJR Am J Roentgenol. 2011 Oct;197(4):W581-9. doi: 10.2214/AJR.11.7536. Review.

PMID:
21940530
44.

Cystic artery localization with a three-dimensional angiography vessel tracking system compared with conventional two-dimensional angiography.

Wang X, Shah RP, Maybody M, Brown KT, Getrajdman GI, Stevenson C, Petre EN, Solomon SB.

J Vasc Interv Radiol. 2011 Oct;22(10):1414-9. doi: 10.1016/j.jvir.2011.02.022. Epub 2011 May 5.

PMID:
21546264
45.

CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.

Sofocleous CT, Petre EN, Gonen M, Brown KT, Solomon SB, Covey AM, Alago W, Brody LA, Thornton RH, D'Angelica M, Fong Y, Kemeny NE.

J Vasc Interv Radiol. 2011 Jun;22(6):755-61. doi: 10.1016/j.jvir.2011.01.451. Epub 2011 Apr 22.

46.

Pulmonary thermal ablation in patients with prior pneumonectomy.

Sofocleous CT, May B, Petre EN, Gonen M, Thornton RH, Alago W, Rizk NP, Dupuy DE, Solomon SB.

AJR Am J Roentgenol. 2011 May;196(5):W606-12. doi: 10.2214/AJR.10.5154.

PMID:
21512052
47.

A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years.

Thornton RH, Covey A, Petre EN, Riedel ER, Maluccio MA, Sofocleous CT, Brody LA, Getrajdman GI, D'Angelica M, Fong Y, Brown KT.

Cancer. 2009 Nov 1;115(21):5000-6. doi: 10.1002/cncr.24556.

Supplemental Content

Loading ...
Support Center